Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients
Nenhuma Miniatura disponível
Data
2020-09-01
Autores
Deffune, Elenice [UNESP]
Prudenciatti, Aruã [UNESP]
Moroz, Andrei [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
As an emerging global health challenge, COVID-19 requires international knowledge to reach novel possible therapeutic strategies, especially for intensive-care patients. During the early stages of infection, pneumocytes II are the primary infected cells, harming the respiratory system. We have previous evidence in murine models that MSc's secretome can be used to treat pulmonary injuries induced with bleomycin, due to its content: growth factors, extracellular vesicles, and exosomes. We hypothesize and strongly recommend MSc secretome testing and production, in xenofree conditions, to be used as an alternative approach in SARS-Cov-2 patients in critical conditions.
Descrição
Palavras-chave
COVID-19, MSc secretome, Novel strategy
Como citar
Medical Hypotheses, v. 142.